IMPROVING ACCESS TO DIAGNOSIS, TREAMENT AND CARE
    FOR PATIENTS WITH RARE DISEASES

    RDAF Board of Directors

    The Board of Directors is composed of at least three members who are elected once a year by the General Assembly. It implements the RDAF strategy defined annually by the General Assembly and oversees the activities carried out by the Working Group.

    Shayesteh Fürst-Ladani

    SFL Pharma

    Shayesteh Fürst-Ladani

    SFL Pharma

    President of the Board

    Reto Kessler

    VERTEX

    Reto Kessler

    Vertex

    Board Member

    Rea Lal

    Pfizer

    Rea Lal

    Pfizer

    Board Member

    Elisabeth Minder

    Swiss Society for PorPhyria

    Elisabeth Minder

    Swiss Society for PorPhyria

    Board Member

    Jacqueline de Sá

    ProRaris

    Jacqueline de Sá

    ProRaris

    Board Member

    Alessandro Strebel

    Roche

    Alessandro Strebel

    Roche

    Board Member

    Andreas Uttenweiler

    Takeda

    Andreas Uttenweiler

    Takeda

    Board Member